Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CASP6 | P55212 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.51 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.51 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.51 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.43 |
| ▸ | NSD2 | O96028 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29610078 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL31229304 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL30566330 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL591403 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL29429619 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL11426413 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL2730688 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| Hydrochloric Acid SCHEMBL8219485 | 0.98 | NT5E (0.66) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL2730683 | 0.98 | NT5E (0.66) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL11426409 | 0.98 | NT5E (0.66) | NT5EALDH1A1CASP6HSD17B10CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689661-A2 | RAPID GLYCAN SAMPLE PREPARATION METHODS, SYSTEM AND KITS | Phenomenex, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-12528916-B2 | Transmembrane pH-gradient polymersomes | ETH ZURICH (CH) | 2026-01-20 | — | — | US | claimed |
| US-12286574-B2 | Manipulating hydrophilicity of conventional dye molecules for tracer applications | SAUDI ARABIAN OIL COMPANY (SA) | 2025-04-29 | — | — | US | claimed |
| US-12210027-B2 | Glycan sample preparation | BECKMAN COULTER, INC. (US) | 2025-01-28 | — | — | US | claimed |
| WO-2024226634-A2 | RAPID GLYCAN SAMPLE PREPARATION METHODS, SYSTEM AND KITS | PHENOMENEX, INC. (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4450530-A1 | MODIFIED RESINS BASED ON RESINOUS OLIGOMERIC OR POLYMERIC PHENOLIC MATERIALS | Prefere Resins Holding GmbH (DE) | 2024-10-23 | — | — | EP | claimed |
| US-11999829-B2 | Method of making a polymersome | ETH ZURICH (CH) | 2024-06-04 | — | — | US | claimed |
| CN-117925241-A | ITO-Ag etching solution for low-damage display panel, and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-114890920-B | Waterproof locking agent and preparation method thereof | 东营施普瑞石油工程技术有限公司 | 2023-12-12 | — | — | CN | claimed |
| US-11815488-B2 | Use of tri- and tetra-hydroxyl quaternary ammonium compounds as resolving agents for electrophoretic separations | AGILENT TECHNOLOGIES, INC. (US) | 2023-11-14 | — | — | US | claimed |
| EP-0048692-A1 | Azo coupling process | CIBA-GEIGY AG (CH) | 1982-03-31 | — | — | EP | claimed |
| EP-0009092-B1 | PROCESS FOR PREPARING 1-AMINO-8-NAPHTHOL-3,6-DISULFONIC ACID (H ACID) | BAYER AG (DE) | 1981-08-05 | — | — | EP | claimed |
| EP-0002691-B1 | PROCESS FOR THE PREPARATION OF 1-AMINO-NAPHTHALINE-3,6,8-TRISULFONIC ACID | BAYER AG (DE) | 1981-06-03 | — | — | EP | claimed |
| EP-0000495-B1 | PROCESS FOR THE PREPARATION OF 1-AMINO-8-HYDROXY NAPHTHALENE-3,6-DISULPHONIC ACIDS (H-ACIDS). | BAYER AG (DE) | 1980-11-26 | — | — | EP | claimed |
| EP-0000493-B1 | PROCESS FOR THE PREPARATION OF 1-AMINO-8-HYDROXY-NAPHTHALENE-3,6-DISULPHONIC ACID (H ACID). | BAYER AG (DE) | 1980-01-09 | — | — | EP | claimed |
| US-4178308-A | Process for the preparation of 1-amino-8-naphthol-3,6-disulphonic acid (H-acid) | BAYER AKTIENGESELLSCHAFT (DE) | 1979-12-11 | — | — | US | claimed |
| US-4166826-A | Process for the preparation of 1-amino-8-naphthol-3,6-disulphonic acid (H-acid) | BAYER AKTIENGESELLSCHAFT (DE) | 1979-09-04 | — | — | US | claimed |
| EP-0002691-A1 | Process for the preparation of 1-amino-naphthaline-3,6,8-trisulfonic acid | BAYER AG (DE) | 1979-07-11 | — | — | EP | claimed |
| EP-0000493-A1 | Process for the preparation of 1-amino-8-hydroxy-naphthalene-3,6-disulphonic acid (H acid). | BAYER AG (DE) | 1979-02-07 | — | — | EP | claimed |
| EP-0000495-A1 | Process for the preparation of 1-amino-8-hydroxy naphthalene-3,6-disulphonic acids (H-acids). | BAYER AG (DE) | 1979-02-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528916-B2 | Transmembrane pH-gradient polymersomes | AQP4, ABCB11, SLC6A6 | NT5E 2104/4885ALDH1A1 3104/4885CASP6 203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.